Anebulo Pharmaceuticals, Inc. (ANEB) vs Palatin Technologies, Inc. (PTN)
Anebulo Pharmaceuticals, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Palatin Technologies, Inc. are of similar size ($17.6M and $17.5M). Anebulo Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Anebulo Pharmaceuticals, Inc. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (0.00% vs −942.3%). Across the 12 metrics below, Anebulo Pharmaceuticals, Inc. leads on 8 and Palatin Technologies, Inc. on 4.
Valuation
Profitability
| Metric | ANEB | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (49.26%) | 0.00% |
| Net margin | 0.00% | (47.22%) | 0.00% |
| Free cash flow margin | 0.00% | (113.25%) | 0.00% |
| Return on equity | (69.69%) | (297.25%) | (57.72%) |
| Return on assets | (63.17%) | (73.72%) | (49.22%) |
| Return on invested capital | 0.00% | (942.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack